Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Austria Belgium France Germany Italy Poland +1
  • Study of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery

    Not recruiting

    1 1
    Investigated drugs:
    France Germany Italy Poland Spain Sweden
  • Study Comparing Erdafitinib with Vinflunine, Docetaxel, or Pembrolizumab for Patients with Advanced Urothelial Cancer and FGFR Gene Changes

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France Spain
  • Study of TYRA-300 for Patients with Advanced Bladder Cancer and Other Solid Tumors with FGFR3 Gene Changes

    Not recruiting

    1 1
    Investigated drugs:
    France Italy Spain
  • Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

    Not recruiting

    1 1 1 1
    Austria Belgium Czechia France Greece Hungary +7
  • Study on the Effectiveness and Safety of Tiragolumab, Atezolizumab, and Drug Combination for Patients with Urothelial Carcinoma

    Not recruiting

    1 1 1
    France Greece Spain
  • Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

    Not recruiting

    1 1 1 1
    Belgium Czechia France Germany Greece Hungary +5
  • Study of Futibatinib and Pembrolizumab for Patients with Advanced or Metastatic Bladder, Urethra, or Pelvis Cancer Not Suitable for Platinum Treatment

    Not recruiting

    1 1 1
    Investigated drugs:
    France
  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    1 1
    Investigated drugs:
    Greece Hungary Romania
  • Study Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Belgium Denmark France Germany Greece +7